Vaccine will spur even more Pfizer growth

Article Excerpt

Pfizer’s shares hit a new all-time high of $52 in August 2021 thanks largely to the huge success of its COVID-19 vaccine. New orders for the vaccine, as well as its other drugs as hospitals resume normal operations, should continue to fuel its share price gains—and your dividends. PFIZER INC. $48 is a top pick or 2021. The company (New York symbol PFE; Income-Growth Dividend Payer Portfolio, Manufacturing sector; Shares outstanding: 5.6 billion; Market cap: $268.8 billion; Dividend yield: 3.3%; Dividend Sustainability Rating: Highest; www.pfizer.com) began operating in 1849 and is now one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia). With the March 2021 payment, Pfizer raised your dividend by 2.6%. Investors now receive $0.39 a share instead of $0.38. The new annual rate of $1.56 yields a solid 3.3%. Pfizer’s overall revenue rose 8.4%, from $38.66 billion in 2016 to $41.91 billion in 2020. Those figures exclude the contribution…